Bonraybio CoTPE:6955 65 FCF Margin % is 37.95% as of Dec. 2025, which is 422% above its 10-year median of 7.27. GuruFocus rates TPE:6955 with a GF Score™ of 65/100 and a GF Value™ of NT$184.74 (Possible Value Trap). The stock has 4 warning signs investors should review. Among 817 Medical Devices & Instruments companies, Bonraybio Co ranks better than 91.8% on this metric.
FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Bonraybio Co's Free Cash Flow for the
three
months ended in Dec. 2025 was NT$31.2 Mil. Bonraybio Co's Revenue for the
three
months ended in Dec. 2025 was NT$82.2 Mil. Therefore, Bonraybio Co's FCF Margin % for the quarter that ended in Dec. 2025 was 37.95%.
The historical rank and industry rank for Bonraybio Co's FCF Margin % or its related term are showing as below:
TPE:6955'
s FCF Margin % Range Over the Past 10 Years
Min: -108.26 Med: 7.27 Max: 31.01
Current: 21.47
During the past 6 years, the highest FCF Margin % of Bonraybio Co was 31.01%. The lowest was -108.26%. And the median was 7.27%.
TPE:6955's FCF Margin % is ranked better than 91.8% of 817
companies
in the Medical Devices & Instruments industry
Industry Median: -0.34
vs TPE:6955: 21.47
Bonraybio Co FCF Margin % Related Terms
Bonraybio Co FCF Margin % Historical Data
* Premium members only.
The historical data trend for Bonraybio Co's FCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TPE:6955 vs ABT, SYK, MDT: FCF Margin % Comparison
For the Medical Devices subindustry, Bonraybio Co's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Bonraybio Co FCF Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Bonraybio Co's FCF Margin % distribution charts can be found below:
* The bar in red indicates where Bonraybio Co's FCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Bonraybio Co (TPE:6955) has a FCF Margin % of 37.95% as of Dec. 2025. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Bonraybio Co and its competitors. This is 422% above median its historical median of 7.27. According to the industry distribution chart, Bonraybio Co ranks #67 out of 817 companies in the Medical Devices & Instruments industry, placing it in the top 8.2%.
Is Bonraybio Co's FCF Margin % too high?
Bonraybio Co's current FCF Margin % of 37.95% is 422% above median its 10-year median of 7.27. Based on the distribution chart, Bonraybio Co ranks #67 out of 817 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Bonraybio Co has a GF Score™ of 65/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Bonraybio Co's FCF Margin % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Bonraybio Co ranks #67 out of 817 companies for FCF Margin %. This places Bonraybio Co in the top 8% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Medical Devices & Instruments company?
A good FCF Margin % depends on the Medical Devices & Instruments industry context. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Bonraybio Co and its competitors. Bonraybio Co's current FCF Margin % is 37.95%, which is 422% above median its own 10-year median of 7.27. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bonraybio Co stock overvalued right now?
Based on GuruFocus' analysis, Bonraybio Co (TPE:6955) is currently considered Possible Value Trap. The stock's GF Value™ is NT$184.74, compared to a current price of NT$120.50 — trading 34.8% below its estimated fair value. The current FCF Margin % is 37.95%, which is 422% above median its 10-year median of 7.27. Bonraybio Co's overall GF Score™ is 65/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Bonraybio Co (TPE:6955), the current FCF Margin % is 37.95% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Bonraybio Co (TPE:6955) Overvalued in 2026?
Based on GuruFocus' analysis, Bonraybio Co stock appears to be undervalued.
The current stock price of NT$120.50 is trading 34.8% below its estimated GF Value™ of NT$184.74.
GuruFocus considers Bonraybio Co to be Possible Value Trap.
Key valuation signals for TPE:6955:
FCF Margin %: 37.95% (422% above median its 10-year median of 7.27)
GF Value™: NT$184.74 vs. price of NT$120.50 (34.8% below fair value)
No single metric tells the full story. See the TPE:6955 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Bonraybio Co Ltd engages in research, development, and manufacturing of vitro diagnostic devices. The firm produces semen quality analyzers and Semen Analysis Systems for the clinic.
65GF Score
Get the complete analysis for TPE:6955
FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TPE:6955 has been successfully added to your 
